Australia markets open in 43 minutes

Castle Biosciences, Inc. (CSTL)

NasdaqGM - NasdaqGM Real-time price. Currency in USD
Add to watchlist
19.20+0.36 (+1.91%)
At close: 04:00PM EDT
19.20 0.00 (0.00%)
After hours: 05:56PM EDT
Currency in USD

Valuation measures4

Market cap (intra-day) 519.74M
Enterprise value 291.98M
Trailing P/E 478.00
Forward P/E N/A
PEG ratio (5-yr expected) N/A
Price/sales (ttm)2.30
Price/book (mrq)1.33
Enterprise value/revenue 1.33
Enterprise value/EBITDA -6.48

Trading information

Stock price history

Beta (5Y monthly) 0.92
52-week change 3-21.57%
S&P500 52-week change 321.61%
52-week high 326.70
52-week low 39.26
50-day moving average 321.71
200-day moving average 319.03

Share statistics

Avg vol (3-month) 3238.89k
Avg vol (10-day) 3124.22k
Shares outstanding 527.59M
Implied shares outstanding 627.97M
Float 826.64M
% held by insiders 14.27%
% held by institutions 189.79%
Shares short (28 Mar 2024) 41.43M
Short ratio (28 Mar 2024) 44.49
Short % of float (28 Mar 2024) 46.21%
Short % of shares outstanding (28 Mar 2024) 45.22%
Shares short (prior month 29 Feb 2024) 41.21M

Dividends & splits

Forward annual dividend rate 4N/A
Forward annual dividend yield 4N/A
Trailing annual dividend rate 30.00
Trailing annual dividend yield 30.00%
5-year average dividend yield 4N/A
Payout ratio 40.00%
Dividend date 3N/A
Ex-dividend date 4N/A
Last split factor 2N/A
Last split date 3N/A

Financial highlights

Fiscal year

Fiscal year ends 31 Dec 2023
Most-recent quarter (mrq)31 Dec 2023

Profitability

Profit margin -26.15%
Operating margin (ttm)-8.56%

Management effectiveness

Return on assets (ttm)-9.43%
Return on equity (ttm)-14.54%

Income statement

Revenue (ttm)219.79M
Revenue per share (ttm)8.20
Quarterly revenue growth (yoy)72.50%
Gross profit (ttm)N/A
EBITDA -55.65M
Net income avi to common (ttm)-57.47M
Diluted EPS (ttm)-2.14
Quarterly earnings growth (yoy)N/A

Balance sheet

Total cash (mrq)243.1M
Total cash per share (mrq)8.86
Total debt (mrq)15.41M
Total debt/equity (mrq)3.94%
Current ratio (mrq)6.20
Book value per share (mrq)14.27

Cash flow statement

Operating cash flow (ttm)-5.63M
Levered free cash flow (ttm)818.5k